Centre to roll out triple-drug therapy to eliminate filaria

PUNE: The Union government has approved the roll-out of the WHO-recommended new triple-drug therapy (TDT) in four select districts, including one in Maharashtra, to eliminate lymphatic filariasis (LF) from the country.

TDT, which uses Ivermectin, Diethylcarbamazine Citrate (DEC) and Albendazole, will also be rolled out in one district each in Uttar Pradesh, Bihar and Jharkhand.

Centre to roll out triple-drug therapy to eliminate filaria

The studies carried out in other countries have shown that TDT is more effective than the existing two-drug therapy in permanently eliminating the micro-filariae infection. Thus, it becomes all the more important for a country like India, which bears approximately 40% of the global LF burden. In India, 650 million are people at the risk of contracting the disease across 256 districts in 21 states and Union Territories.

A senior health official from the Union health ministry said, “The Indian Council of Medical Research (ICMR) has recommended a phased introduction of TDT, following study trials by the Vector Control Research Centre (VCRC), Puducherry, which showed the safety and efficacy of the new drug therapy. It will soon be rolled out.”

Veteran epidemiologist Kapa D Ramaiah said, “Global and Indian clinical trials have shown that a single dose of triple-drug therapy cleared more than 95% microfilaria load in infected people. With such an excellent effect, annual mass TDT can eliminate LF from endemic communities in two to three years. This will enable India to effectively meet the target set by WHO to eliminate LF by 2020.”

The Maharashtra chief minister’s (CM) office sent a letter to the National Vector Borne Disease Control Programme (NVBDCP) expressing interest in rolling out TDT in the state’s endemic districts. This means that Maharashtra could well become the first Indian state to adopt the therapy and achieve the elimination of LF by 2020.

“TDT will soon be rolled in the endemic districts of Maharashtra. These districts are mainly in the Vidarbha region. We are awaiting guidelines from the Union health ministry in this regard. It will help accelerate elimination efforts,” MS Diggikar, joint director (vector-borne diseases), state health department, said.

The biggest challenges on the ground include alarmingly low awareness and negligible attention given to eliminating LF in public and political discourse, experts said.

  • Related Posts

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre